Abemaciclib + Endocrine or HER2-Targeted Therapies in Metastatic Breast Cancer

Slideset - Abemaciclib combined with endocrine or HER2-targeted therapies was safe and active in patients with MBC.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research